The companies will provide access to IrysSolve, BioNano's whole-genome analysis algorithms and pipeline, on DNAnexus' cloud platform.
The so-called precisionFDA system will provide a forum for sharing data and software as well as deriving standards to enable NGS-based testing
DNANexus will handle data from CareDx's cell-free transplant assay as well as support its ongoing research and development activities.
Using funds from the California precision medicine initiative, the group will use its bioinformatics expertise to match patients to treatments in pediatric clinical trials.
The initiative aims to integrate clinical, genomic, environmental, and other data from patients to help determine disease mechanisms and develop precise therapies.
DNAnexus' platform will support data analysis and sharing for the third phase of the Encyclopedia of DNA Elements project.
The so-called HgV platform offers tools for analyzing high-throughput whole genome sequence data for precision medicine research and clinical applications
The 3000 Rice Genomes Project will use DNANexus' platform in effort to improve nutrition, climate tolerance, and disease resistance in rice.
In addition to the investment, WuXi NextCode is partnering with DNAnexus to offer cloud-based analysis infrastructure to customers in China.
Customers of both companies' cloud-based platforms will have access to their respective genome analysis and interpretation pipelines.
GenomeWeb reports that Veritas Genetics is suspending its US operations.
A Brazilian-led team of researchers reports it has generated a sugarcane genome assembly that encompasses more than 99 percent of its genome.
Certain plasma proteins could be used to gauge a person's age and whether they are aging well, according to HealthDay News.
In Science this week: approach to measure microRNA targeting efficiency, strategy to conduct high-throughput chemical screens at single-cell resolution, and more.